ATS: Benralizumab Reduces Glucocorticoid Doses in Asthma
Significant 75 percent reduction in median final oral glucocorticoid doses from baseline
Source: Pulmonary Medicine News - Doctors Lounge - Category: Respiratory Medicine Tags: Internal Medicine, Allergy, Emergency Medicine, Pharmacy, Pulmonology, Conference News, Source Type: news
More News: Allergy | Allergy & Immunology | Asthma | Conferences | Emergency Medicine | Internal Medicine | Respiratory Medicine